Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp

Generic 16 April 2019 | 0 Comments

Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado. Since 1968, the University of Mississippi farm, which is governed by the US National Institute on Drug Abuse, has […]

Tagged in , , ,

NORML Submits Public Comments To FDA Regarding The International Scheduling Of Marijuana

Generic 15 March 2019 | 0 Comments

The US Food and Drug Administration sought public comments specific to whether changes ought to be recommended regarding imposing international manufacturing and distributing restrictions, under international treaties, on certain drug substances. Per the FDA: FDA, on behalf of the Secretary of HHS, invites interested persons to submit comments on the notifications from the United Nations concerning […]

Tagged in , , ,

Legislation To Produce And Research Cannabis Introduced

Generic 17 January 2019 | 0 Comments

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure.  The act ends the University of Mississippi’s existing monopoly on the growth of cannabis for […]

Tagged in , , ,

FDA Weighs In On Legal Status of Commercially Available ‘Hemp-Derived’ CBD Products

Generic 22 December 2018 | 0 Comments

Following yesterday’s passage of the 2018 Farm Bill, US Food and Drug Administration Commissioner Scott Gottleib issued a statement with regard to the agency’s oversight of products commercially marketed as ‘hemp-derived’ CBD. The FDA states: “We’re aware of the growing public interest in cannabis and cannabis-derived products, including cannabidiol (CBD). This increasing public interest in […]

Tagged in , , ,

NORML Submits 10,000+ Written Comments to the FDA for the Reconsideration of International Marijuana Prohibition

Generic 2 November 2018 | 0 Comments

On October 31, NORML hand delivered over 10,000 comments written by YOU, recommending that the World Health Organization (WHO) re-think their current prohibition of marijuana. Along with two of our fantastic interns, I drove to the US Food and Drug Administration (FDA) building in Rockville, Maryland. Earlier this month, The FDA put out a request […]

Tagged in ,